Charlée Nardin

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study

Nicolas Delanoy, Jean‐Marie Michot, Thibault Comont et al. · The Lancet Haematology · 2018 · 269 citations

Immunohematology, Autoimmune Disease, Lupus +12

Tracking the evolution of circulating exosomal‐PD‐L1 to monitor melanoma patients

Marine Cordonnier, Charlée Nardin, Gaëtan Chanteloup et al. · Journal of Extracellular Vesicles · 2020 · 251 citations · Full text

Immunology, Immunoediting, Pathology +22

Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry*

Gábor Dobos, Adèle de Masson, C. Ram‐Wolff et al. · British Journal of Dermatology · 2020 · 86 citations

Tolerance and outcomes of stereotactic radiosurgery combined with anti-programmed cell death-1 (pembrolizumab) for melanoma brain metastases

Charlée Nardin, Christine Mateus, Mathieu Texier et al. · Melanoma Research · 2018 · 57 citations

Increased Levels of Interleukin-17A Exosomes in Psoriasis

C. Jacquin-Porretaz, M Cordonnier, Charlée Nardin et al. · Acta Dermato Venereologica · 2019 · 39 citations · Full text